RSS affiliated lab to test 1 lakh for sickle cell and thalassaemia
Lok Kalyan Diagnostics
launched a sickle cell,
thalassaemia awareness campaign
, wherein it will provide personalised counselling to patients and conduct blood tests for 1 lakh citizens across Vidarbha by October 2. The initiative aims to elevate public understanding of these genetic blood disorders, strategically timed to coincide with World Thalassaemia Day on May 8.
The campaign was officially inaugurated on May 1. Dr Prashant Joshi, director of AIIMS; Jai Prakash Dwivedi, CMD of WCL; Hemant Pandey, director (HR), WCL; social activist Dadaji Kothe; Dr Vijaykumar Tungar, chairman of Lok Kalyan Diagnostics; and Dr Dilip Gupta, chairman of the Lok Kalyan Samiti were present.
Dr Prashant Joshi emphasised the institution's commitment, stating, "AIIMS established a dedicated sickle cell unit where patients receive free treatment. Also, we are on the verge of launching a new bone marrow laboratory, which will significantly enhance our diagnostic capabilities and support for patients."
JP Dwivedi assured full cooperation, noting, "The public welfare committee can count on our complete support. A significant 60% of WCL's CSR funds are specifically allocated to the healthcare sector, reflecting our commitment to the well-being of the community."
During the event, Lok Kalyan Diagnostics shared significant data gathered from their screening efforts across 9 districts of Vidarbha. To date, 58,293 individuals were screened through 496 camps. The findings revealed that 3,459 individuals were identified as carriers of either sickle cell or thalassaemia. The total percentage of carriers stands at a high 5.93% in Vidarbha.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
4 hours ago
- New Indian Express
AIIMS now set to roll out smart card payment system across all branches
NEW DELHI: All India Institute of Medical Sciences (AIIMS) is preparing to expand its smart card-based payment system across the country that is currently in use only at its Delhi institute. The move comes under the Centre's 'One AIIMS, One Card' initiative, aimed at making hospitals cashless and easing the financial transaction process for patients. Initially launched in February 2024, the AIIMS smart card was developed in collaboration with the State Bank of India to streamline payments for treatment, tests, and other hospital expenses. The card is linked to the patient's Unique Health Identification Number (UHID) and ABHA (Ayushman Bharat Health Account), allowing digital payments and enabling a unified system of tracking healthcare expenditure. Officials said, 'Preparations are underway to make the system functional at other AIIMS branches as part of a unified national model. Once adopted nationally, the smart card will allow patients to pay for medical services in any AIIMS facility using the same card.' The card will not only promote cashless payments but also eliminate the need for patients to carry physical cash, which is particularly useful for those travelling from other states for treatment, they added. 'The smart card addresses this issue by allowing patients or their families to deposit money digitally into the card from anywhere in the country, even in emergency situations. The feature could prove useful, especially in rural areas where patients may not have access to banking services or debit cards,' a hospital official said. The initiative was initially piloted in December 2023, with the card being introduced for use by hospital staff in the cafeteria. It was subsequently rolled out for patients in the maternal and child block and is being gradually extended to all departments at Delhi AIIMS. While AIIMS Delhi already supports digital payments via debit cards, credit cards, and UPI, the smart card offers a dedicated, hospital-integrated solution. Patients can top up their cards online and maintain a balance that can be used to pay for a wide range of medical services, officials said.
Time of India
8 hours ago
- Time of India
Why kidney patients should never mix coconut and banana: Hidden dangers to know
If you're living with kidney issues, chances are you already know your grocery list has to be carefully curated. But one seemingly innocent pair might cause extra trouble: coconut and banana. Why are these two tropical goodies particularly risky—especially when eaten together? Set down that smoothie and let's break it down. Potassium is an essential mineral your body uses for muscle contractions, nerve function, and keeping your heartbeat regular. Usually, your kidneys keep potassium levels in check by filtering out what your body doesn't need. But for patients with weakened or failing kidneys, this system gets wonky. Suddenly, even everyday foods can send potassium levels soaring. Bananas are notorious for being potassium powerhouses. A single medium banana boasts about 375–487mg of potassium more than enough to land it on the kidney patient's 'handle with care' list. Coconut especially coconut water and coconut meat might seem like a hydrating, harmless treat. But coconuts pack an impressive amount of potassium too, often flying under the radar. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Do you have a mouse? Desert Order Undo Even a moderate serving can tip the scales. Eating these separately is already risky for many kidney patients. Put them together, and you've got a recipe for hyperkalemia that's a medical way of saying 'too much potassium in your blood,' and trust us, it's more dangerous than it sounds. On this risk factor of kidney, AIIMS doctor Parwez says, "when the kidney doesn't function properly, potassium elimination gets difficult. When the level of potassium in the blood increases, it increases the risk of heart attack. And in such cases eating high potassium foods like bananas or coconut, or eating them together, can pose a great risk to the body." In the video, the doctor urges people to refrain from consuming these fruits together and even separately. What happens if potassium gets too high? High potassium levels can cause: Muscle weakness or cramps Fatigue Nausea or irregular heartbeat Serious heart problems like arrhythmia—or, in extreme cases, cardiac arrest. Not exactly what you want from a fruit salad. Once your kidneys are struggling, there's no good way for your body to kick out that extra potassium on its own. So, every high-potassium snack you include adds up—and fast. Why not just eat a little? Sometimes folks wonder, 'Can't I just have a little banana and coconut—just a taste?' With kidney disease, even 'a little' isn't as safe as it sounds. There's no reliable way to predict how much potassium is hiding in a piece of fruit, and your body isn't very forgiving if you overshoot your daily limit. Plus, the effects aren't always immediate. Potassium creeps up in your blood, and by the time you feel symptoms, the damage might already be underway. Lots of fruits and veggies carry a health halo, and for good reason. But kidney issues flip the script. Foods high in potassium—including bananas, avocados, coconut water, oranges, tomatoes, potatoes, and spinach—should be limited or avoided if you've got chronic kidney disease (CKD). Not convinced? Even recommended diet plans for kidney patients will tell you to steer clear of these two, often skipping them completely from weekly menus. Are there safe alternatives? Absolutely! Swap out high-potassium fruits for lower-potassium ones like: Apples Berries (strawberries, blueberries) Pineapple Grapes Pears These can deliver flavor and nutrients without the high-risk potassium spike. Kidney patients shouldn't just avoid coconut and banana together—they should treat this pair like forbidden fruit. When your body can't filter potassium, every food choice matters. Both coconut and banana sneak in a hefty potassium punch that your kidneys simply can't handle, and mixing them multiplies your risk for dangerous complications. So next time a coconut-banana smoothie tempts you, remember: your kidneys will thank you for saying 'no,' and there are plenty of safe, delicious options waiting on the next aisle. Consult your dietitian, plan ahead, and keep those potassium numbers in check—it's the wise (and delicious) choice for your health.
The Hindu
19 hours ago
- The Hindu
All you need to know about: sarcoidosis
Sarcoidosis is an inflammatory condition that can affect several organs. A disease of unknown etiology or chronic inflammation can lead to permanent scarring of the affected tissues. Considered a rare disease, research is ongoing to understand further the causes, diagnosis and treatment modalities. What is sarcoidosis? Sarcoidosis is believed to be an exaggerated response of the immune system either due to a genetic disposition or due to environmental triggers. It results in affected people developing lumps on their skin or in other parts of the body. The Mayo Clinic website describes the lumps or clusters of immunity cells in an organ as 'tiny collections of immune system cells in any part of the body,' which are red, swollen lumps called granulomas. They commonly occur in lungs and the lymph nodes of the chest, the website adds. What are the symptoms? Persons with sarcoidosis may suffer from a variety of symptoms including fatigue, shortness of breath, wheezing, chronic cough, skin rashes that appear scaly, red eyes, irregular heart beat, weakness or numbness of a limb or part of face, discolouration of the nose, cheek, lips or ears; and chest pain. Some people may remain symptom free as the disease disappears on its own but in some others, though the disease may not progress they may have symptoms that affect their lifestyle. A third of those diagnosed with the condition may require long-term treatment. A person in whom the disease has been active for over two to five years is termed to have a chronic ailment. In such persons, it can be life-threatening. How rare is the condition? In the United States of America an estimated 1.5 to 2 lakh persons live with sarcoidosis. The National Library of Medicine, operated by the United States government, states that the incidence of sarcoidosis is 11 in 1 lakh among the white population and 34 in 1 lakh among the African American population. Across the world an estimated 1.2 million have the condition. In a letter published in 2019 in the Sarcoidosis, Vasculitis and Diffuse Lung Diseases journal, researchers from the All India Institute of Medical Sciences, New Delhi, stated that while the reported prevalence of sarcoidosis in India was estimated to be 10-12 cases per 1,000 new registrations in a respiratory unit at Kolkata and 61.2/100,000 new cases at a centre in New Delhi, 'these figures are unlikely to be a true representation as sarcoidosis is usually unidentified due to the high burden of tuberculosis here. Real figures are anticipated to be much higher.' At AIIMS, Delhi, approximately 100 new cases of pulmonary sarcoidosis are being diagnosed every year, says Rashi Jain, of the department of pulmonary medicine and sleep disorders at AIIMS, Delhi and the main author of the letter. 'The number is quite noticeable for a disease otherwise considered rare,' the letter noted. Organisations working to raise awareness about the disease say approximately five to 10% of all those diagnosed will have advanced sarcoidosis. What are the treatment modalities? Research studies and patient advocate organisations have all called for more research on sarcoidosis to develop effective treatment strategies. Dr. Jain says low awareness about sarcoidosis in India results in doctors misdiagnosing it as tuberculosis. Stating that the condition could cause mental stress due to the multiple evaluations and tests required, she called for exclusive clinics with a multidisciplinary teams of healthcare workers from various specialties, to treat patients with sarcoidosis. Among the affected, around 25% to 30% develop extrapulmonary sarcoid. While in men the heart function is commonly affected, in women, the skin and eyes are more prominently affected. Many persons with the disease recover completely. In those with advanced sarcoidosis (active disease for over two to five years), treatment options include corticosteroids besides other therapies. Persons who require treatment even if they do not have symptoms are also classified as having advanced sarcoidosis. Persons on advanced treatment also need to contend with fatigue, pain, cognitive failure, neuropathy, an inability to exercise and depression besides other comorbidities such as diabetes and high blood pressure.
